Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Endocrinology
|
March 10, 1998
The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats
M Yamamoto, J E Fisher, M Gentile, et al.
Experimental Cell Research
|
August 1, 1995
Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells
G Wesolowski, L T Duong, P T Lakkakorpi, et al.
Cancer Research
|
September 15, 1987
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties
S B Rodan, Y Imai, M A Thiede, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 27, 2004
Disposition of a novel and potent alpha(v)beta3 antagonist in animals, and extrapolation to man
T Prueksaritanont, C Fernandez-Metzler, Y Meng, et al.
Journal of Medicinal Chemistry
|
January 5, 2001
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L
J P Falgueyret, R M Oballa, O Okamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 2, 1996
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate
A Schmidt, S J Rutledge, N Endo, et al.
The Journal of Clinical Investigation
|
October 1, 1983
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells
S B Rodan, K L Insogna, A M Vignery, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology
M Rosenblatt, M P Caulfield, J E Fisher, et al.
Science (New York, N.Y.)
|
December 11, 1987
Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro
N Horiuchi, M P Caulfield, J E Fisher, et al.
Molecular Pharmacology
|
June 16, 2001
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2)
M Machwate, S Harada, C T Leu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Endocrinology
|
March 10, 1998
The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats
M Yamamoto, J E Fisher, M Gentile, et al.
Experimental Cell Research
|
August 1, 1995
Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells
G Wesolowski, L T Duong, P T Lakkakorpi, et al.
Cancer Research
|
September 15, 1987
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties
S B Rodan, Y Imai, M A Thiede, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 27, 2004
Disposition of a novel and potent alpha(v)beta3 antagonist in animals, and extrapolation to man
T Prueksaritanont, C Fernandez-Metzler, Y Meng, et al.
Journal of Medicinal Chemistry
|
January 5, 2001
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L
J P Falgueyret, R M Oballa, O Okamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 2, 1996
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate
A Schmidt, S J Rutledge, N Endo, et al.
The Journal of Clinical Investigation
|
October 1, 1983
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells
S B Rodan, K L Insogna, A M Vignery, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology
M Rosenblatt, M P Caulfield, J E Fisher, et al.
Science (New York, N.Y.)
|
December 11, 1987
Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro
N Horiuchi, M P Caulfield, J E Fisher, et al.
Molecular Pharmacology
|
June 16, 2001
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2)
M Machwate, S Harada, C T Leu, et al.
Page
of 6